PROSPECTUS PERCHERON THERAPEUTICS LIMITED (ACN 095 060 745) This Prospectus is being issued for the offer of up to 280,000,000 New Options as follows (Offers): (a) 230,000,000 New Options to Placement Participants (Placement Options Offer); and (b) 50,000,000 New Options to the Joint Lead Managers...
Prospectus - Placement options and JLM options
Filed with ASX · · 41 pages · English
Summary by 6ix AI
This filing is a prospectus issued by Percheron Therapeutics Limited for the offer of new options to investors. It provides important information regarding the speculative nature of the investment and the associated risks. The document also details the intended use of funds and the company's capital structure following the offers.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Percheron Therapeutics Limited on 6ix
Story so far
Earlier from Percheron Therapeutics
- FDA Clearance for Vanderbilt Health Clinical Trial in AML
- Listing Rule waiver to allow quotation of PERAQ options
- Completion of HMBD-002 Drug Product Manufacture
- Quarterly Activities Report and Appendix 4C
- Photosoft & Novel Immunotherapy Collab Partnership
Later from Percheron Therapeutics
All Percheron Therapeutics news releasesFollow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics